Canada Peptide Guide
Home › Growth hormone › Sermorelin
Growth hormone

Sermorelin

Not authorized in Canada Evidence 2/4
Sermorelin peptide structure illustration (abstract amino-acid chain)
In short

A shortened form of natural GHRH, reviewed in 1999 for use in children with growth hormone deficiency. We found no sermorelin product in Health Canada's Drug Product Database.

Reviewed November 10, 2026 · 3 sources cited below

Also known asGRF 1-29
Canada statusNot authorized in Canada
Human evidence Limited: small or low-quality human studies
Sport (WADA)WADA's Prohibited List bans growth hormone releasing factors and secretagogues (S2) at all times.
Last reviewedNovember 10, 2026

How strong is the human evidence?

Limited: small or low-quality human studies. How we rate evidence

What is Sermorelin?

Sermorelin is the first 29 amino acids of GHRH. A 1999 review describes its use in diagnosing and treating children with idiopathic growth hormone deficiency.

Some clinics now market it for "anti-ageing", which is not an established use.

What the research shows

  • Evidence relates to children with GH deficiency (Prakash & Goa, 1999).

What it doesn't show

  • No good evidence for anti-ageing, body composition or performance in healthy adults.

Common questions

Is sermorelin available in Canada?

We found no authorized sermorelin product in the Drug Product Database.

Sermorelin vs tesamorelin?

Both are GHRH analogs. Tesamorelin was approved for a specific HIV-related use; sermorelin was used for pediatric GH deficiency. Neither has a marketed product in Canada per the DPD.

Sources

  1. Health Canada Drug Product Database (searched Nov 10, 2026)
  2. Prakash A, Goa KL. Sermorelin: a review of its use in children with idiopathic GH deficiency. BioDrugs 1999
  3. World Anti-Doping Agency — Prohibited List

Related

Tesamorelin peptide illustrationTesamorelinA GHRH analog studied and approved for excess abdominal fat in people with HIV-associated lipodystrophy. Its Canadian…Not currently marketed in CanadaCJC-1295 peptide illustrationCJC-1295A long-acting analog of growth hormone-releasing hormone (GHRH). Small human studies exist; it was never approved.…Not authorized in Canada